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evidence suggest that the inhibition of cholesterol
synthesis by statins disrupts these lipid rafts and
thereby influences the function of lymphocytes
(Fig. 1).
Could all the immunomodulation by statins be
ascribed to their ability to reduce cholesterol levels
in the cell membrane? Serum and membrane cho-
lesterol may be differentially affected by statin treat-
ment, and only by assaying both could the full ef-
fects of statins be identified. Although the changes
in membrane cholesterol levels may be relevant only
at sites of lymphocyte activation, as in atheroma or
autoimmune diseases, the possibility that lympho-
cyte function may be generally impaired in the
many patients who are taking statins raises a note
of caution. However, even in the area of infection,
there are suggestions that statin therapy has a fa-
vorable effect on sepsis and can reduce the repli-
cation of the human immunodeficiency virus.
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The notion that the antiinflammatory effects of
statins ameliorate cardiovascular disease suggests
that it should be possible to create other antiin-
flammatory agents, perhaps tailored to the specific
immunologic abnormalities in atheroma. Deter-
mining the mechanisms of action of statins and
their relative importance will help to rationalize the
design of such therapies.
 
From the Centre for Rheumatology, Department of Medicine, Uni-
versity College, London.
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Bacterial Infections — A Major Cause of Death 
among Children in Africa
 
E. Kim Mulholland, M.D., and Richard A. Adegbola, Ph.D.
 
For the past 25 years, since the United Nations
Children’s Fund (UNICEF) has been publishing
estimates of mortality among children worldwide,
the international medical community has been
aware of the appalling burden of early deaths among
African children. Early studies indicated that, in the
absence of any effective medical care, children born
in a rural African village had a probability of death
before the age of five years of 30 to 50 percent.
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 From
the outset, it was understood that many of these
deaths result from the combined effect of poverty
and malnutrition.
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 Since 1980, mortality rates have
fallen but remain high by global standards. Twelve
African countries still report official death rates for
children under the age of five of more than 20 per-
cent. Community-based studies of death among
children have been able to attribute these deaths
to a number of common causes, either syndromes
or specific diseases (Table 1).
These studies have suggested that the most im-
portant cause of death among children in Africa is
malaria. The studies are based on the administration
of a questionnaire in an interview with the family,
conducted after the child’s death, usually by a health
 
Figure 1 (facing page). Effects of Statins on T-Cell 
Activation.
 
Panel A shows Jurkat T cells that were incubated with 
10 µM atorvastatin or medium. The cells were then fixed 
with 4 percent paraformaldehyde and incubated with 
cholera toxin B, labeled with phycoerythrin. Cholera toxin 
B binds to glycosphingolipid GM1, which is a marker for 
lipid-raft domains. T cells exposed to atorvastatin show 
alterations in the expression and distribution of lipid-raft 
domains. In Panel B, the T-cell receptor (TCR) and co-
stimulatory molecules, including lymphocyte function–
associated antigen 1 (LFA-1), CD28, CD4, and CD40 lig-
and (CD40L), are recruited to lipid rafts after activation. 
Statins interfere with the activation of T cells by deplet-
ing membrane cholesterol and disrupting the integrity of 
lipid rafts. Statin treatment causes the exclusion from lip-
id microdomains of raft-associated molecules such as 
the Lck protein tyrosine kinase, the inhibition of actin po-
lymerization, and the formation of a stable immunologic 
synapse and therefore disrupts T-cell activation.
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worker in the home. The findings are then inter-
preted by a physician. Children who have died as a
result of a short illness associated with fever are
generally regarded as having died from malaria.
Coexisting malnutrition is not considered in these
studies. In recent years, community-based studies
of the incidence of invasive bacterial disease caused
by 
 
Haemophilus influenzae
 
 type b or 
 
Streptococcus pneu-
moniae
 
 have been undertaken as part of an attempt
to determine the probable effect of vaccines against
those organisms. Most identified cases were mani-
fested as either pneumonia or meningitis and as
such did not alter perceptions regarding the overall
burden of morbidity and mortality attributable to
bacterial infections.
The study by Berkley et al.
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  in this issue of the
 
Journal 
 
breaks new ground in that it is a population-
based evaluation of the incidence of all invasive
bacterial disease in children living in a rural African
community. The results are both surprising and en-
lightening. The incidence of invasive disease due to
 
H. influenzae
 
 type b and pneumococcus is similar to
that found in other population-based studies from
sub-Saharan Africa. However, this study also pre-
sents data on the incidence of other bacterial infec-
tions, all of which are associated with a substan-
tial and similar risk of death. The annual overall
risk of any bacteremic disease for children was 505
per 100,000 children under the age of five years, a
risk that is equivalent to a 2.5 percent probability of
a child’s acquiring invasive bacterial infection dur-
ing the first five years of life. This figure is much
higher than is the risk of invasive bacterial infec-
tion among U.S. children, and the outcome is much
worse. Since many children in the study area be-
came ill and died without medical care, this num-
ber must represent a substantial underestimation
of the true incidence.
In the study, 28 percent of children admitted to
the hospital with bacteremia died. Even more im-
portant, 26 percent (308 of 1184) of hospital deaths
were associated with bacteremia. This finding com-
pares with 22 percent of the deaths that were asso-
ciated with malaria, suggesting that bacterial dis-
ease may be responsible for more deaths in children
than malaria in this area where malaria is endemic.
Is this an accurate indication of mortality patterns
in the community, given that most deaths of chil-
dren occur in the home? Did the children who died
at home die from a spectrum of causes similar to
that among children who died after reaching the
hospital? Both malaria and bacterial illness are ame-
nable to relatively simple therapeutic approaches,
but antimalarial drugs tend to be more widely avail-
able in African communities than are antibiotics.
Therefore, in a rural community, bacteremia may be
even more important as a cause of death among
children than it is in a hospital setting, since the
management of bacteremic illness in the commu-
nity is likely to be less effective than the manage-
ment of malaria.
The analysis presented by Berkley et al. focuses
on the role of the human immunodeficiency virus
(HIV) and malnutrition as cofactors in bacterem-
ic childhood illness. The prevalence of HIV infec-
tion among pregnant women in the study area was
around 10 percent, which tragically is about aver-
age for sub-Saharan Africa. Both HIV infection and
malnutrition were associated with an increased risk
of bacteremia among children admitted to the hos-
pital, but only 18 percent of children admitted with
bacteremic illness were infected with HIV, whereas
severe malnutrition was present in 37 percent, sug-
gesting that the latter is a more important cofactor.
During the past six years, the world of interna-
tional health care has been dominated by high-pro-
file efforts to control HIV infection, malaria, and
tuberculosis. Of these, malaria is seen as the most
important contributor to death among children in
 
* Data are from the World Health Organization (WHO)
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and reflect the WHO African region, which excludes 
most North African countries, Somalia, and Sudan. 
Many of the deaths that were classified as due to “other 
causes” may actually belong among the main causes list-
ed. A total of 54 percent of all deaths among children are 
believed to be associated with malnutrition. HIV denotes 
human immunodeficiency virus, and AIDS the acquired 
 
immunodeficiency syndrome.
 
Table 1. Official Estimates of Mortality among Children 
under 5 Years of Age According to Cause in Sub-Saharan 
Africa and Globally in 2002.*
Cause of Death Africa Global
 
percent
 
Acute respiratory infection 16 18
Diarrheal disease 14 15
Malaria 22 10
Measles 8 5
HIV or AIDS 8 4
Neonatal deaths 13 23
Other causes 19 25
 
number
 
All causes 4.5 million 10.9 million
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Africa. This study gives us cause to question wheth-
er this very narrow, disease-based approach is in-
deed appropriate and whether the most important
causes of death among children have been appro-
priately targeted. Even in an area of rural Kenya with
high rates of HIV infection and malaria, there ap-
pear to be more deaths of children associated with
bacterial infection than with malaria, with malnu-
trition still the main cofactor. Global health strate-
gies, like any other public health activities, should
be based on evidence. This study has highlighted
just how weak is our understanding of the causes
of death among children in Africa.
Control of the problem of bacterial infections
is complex. Vaccines against 
 
H. influenzae
 
 type b have
already been introduced in a number of African
countries, including Kenya, with the assistance of
the Global Alliance for Vaccines and Immuniza-
tion. Sadly, there is now concern about the sustain-
ability of those programs, although the study by
Berkley et al. provides further evidence of the impor-
tance of 
 
H. influenzae
 
 type b in African children and,
for the first time, gives an indication of the effect of
this pathogen on mortality. The currently available
pneumococcal conjugate vaccine is very expensive
and covers a limited range of serotypes, yet this ap-
proach may have an important role in the preven-
tion of pneumococcal disease in the future, probably
in combination with the 23-valent pneumococcal
polysaccharide vaccine. In the study by Berkley et
al., more than 70 percent of pneumococcal isolates
in children who were old enough to have been vac-
cinated were of serotypes that are included in the
nine-valent conjugate vaccine, which has undergone
trials in South Africa and the Gambia. A much
lower proportion of isolates would be included in
the commercially available seven-valent vaccine,
which lacks the dominant serotype 1, which was re-
sponsible for 24 percent of isolates in the study. 
For the remaining causes, there are no vaccines
available at present. Thus, prevention of deaths
from these conditions rests with improvement in
the living conditions of children, reduction in the
high rates of malnutrition, improved recognition of
illness requiring medical care, and more prompt
treatment with antibiotics and lifesaving supportive
measures such as oxygen and fluids. Evidence that
prompt treatment is necessary was found in the
high proportion of deaths associated with bactere-
mia that occurred in children who were newly ad-
mitted to the hospital. Presumably, if such children
had been identified and treated earlier, many of the
deaths might have been averted.
There is no substitute for the provision of an
adequate and accessible health care system that
can deal with the treatable causes of death in chil-
dren, such as bacterial infection. There are no short-
cuts. Under the Convention on the Rights of the
Child, countries are now obliged to provide ade-
quate health services for their children. Such ser-
vices must be comprehensive, integrated, and ac-
cessible to all. The lack of functional, basic health
services stands as a major barrier to resolving the
global tragedy of mortality among children, partic-
ularly in sub-Saharan Africa.
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From the Centre for International Child Health, University of
Melbourne, Melbourne, Australia (E.K.M.); and the Bacterial
Diseases Programme, Medical Research Council Laboratories,
Fajara, the Gambia, West Africa (R.A.A.).
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